Navigation Links
Drugs.com Releases Q4 Sales for Top 100 U.S. Drugs
Date:2/13/2013

NEW YORK, Feb. 13, 2013 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today released fourth quarter 2012 U.S. prescription sales data for the top 100 drugs.

At the close of 2012, Otsuka's antipsychotic Abilify overtakes AstraZeneca's acid reducer Nexium and moves into the number one spot with over $1.47 billion in quarterly sales. Sales expanded for all five front-runners over the quarter, although none reached double-digit growth. There are no changes in the top selling pharmaceutical classes, which include antipsychotics, proton pump inhibitors, and statins.Top Five Drugs by Sales, Q4 2012Drug Name  

Gain ($000)  

% Change (previous quarter)budesonide$79,295

+42.52%Abilify$73,075

+5.20%Cymbalta$69,131

+5.97%Lantus Solostar

$62,028

+11.58%Advair Diskus$56,263

+4.90%Top Five Sales Losses, Q4 2012Drug Name

Gain ($000)% Change (previous quarter)TriCor-$128,731

-41.58%Neulasta-$29,497

-3.54%Incivek-$26,778

-9.14%One Touch Ultra

-$24,687

-6.59%Avonex-$20,275

-5.17%AbbVie's cholesterol treatment TriCor drops 53 spots with a $129 million sales decline in Q4 2012 even though it did not lose patent protection until January of 2013. Neulasta, Incivek and Avonex also report declining sales of $20 to $30 million.

"The top five brands maintained their leading positions in the last quarter of 2012." said Philip Thornton , CEO of Drugs.com. "Fewer blockbuster brands lost exclusivity, however 2013 will bring a new round of generic competition highlighted by the expected Cymbalta patent loss later this year."

Zomig and Aciphex are additional top-selling brands expected to lose patent protection in 2013.

Detailed data on the top 100 drugs can be accessed at: 
http://www.drugs.com/stats/top100/sales

About Drugs.com

Drugs.com is the leading online drug information resource with over nine million unique visitors per month (ComScore, January 2013). Providing free, independent, peer-reviewed, and up-to-date information at both consumer and professional levels, Drugs.com empowers patients and caregivers to take charge of their health and be more informed than ever before. The site includes many interactive tools and mobile apps to assist consumers, healthcare professionals and researchers, such as personal medication records, a drug interaction checker, pill identification wizard, symptom checker, pharma sales statistics and more.

For more information, visit: www.drugs.com

Media Inquiries: 
Drugs.com Press Officer 
press@drugs.com 
(718) 395 2473

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

 


'/>"/>
SOURCE Drugs.com
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Latest Drug Sales Data: Loss of Patent Protection Has Significant Effect, According to Drugs.com
2. Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
3. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
4. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
5. ShelfX Releases A Fridge That Knows What You Took
6. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
7. Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System
8. Simbionix Releases Two New Platforms at the Upcoming DDW and AUA Events
9. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
10. MD Bioproducts releases HLA-B27 subtype specific antibody.
11. ChemDAQ Releases First Sensor For Detection Of Peracetic Acid In Air
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... -- DaVita Inc. (NYSE: DVA ) today announced ... Net income attributable to DaVita Inc. for ... million, or $0.80 per share and $880 million, or $4.29 ... to DaVita Inc. for the quarter and year ended December ... million, or $0.98 per share, and $789 million, or $3.85 ...
(Date:2/16/2017)... ST. LOUIS , Feb. 16, 2017  Express Scripts (NASDAQ: ... one of the World,s Most Admired Companies within the Health Care: ... to be named one of the World,s Most Admired Companies," said ... is driven by the commitment and passion of our 26,000 employees ... people we serve." ...
(Date:2/16/2017)... , Feb 16, 2017 Research and Markets ... Diagnostics Market Analysis & Trends - Function, Application, Cancer Type, Technology ... ... Cancer Diagnostics Market is poised to grow at a CAGR of ... by 2025. Some of the prominent trends ...
Breaking Medicine Technology:
(Date:2/18/2017)... Aliso Viejo, CA (PRWEB) , ... February 18, ... ... styled animating paragraph presets. Use Pixel Film Studios ’ ProParagraph Fashion ... listings, descriptions, and so many other applications. Users can pick and choose ...
(Date:2/17/2017)... Ocala, FL (PRWEB) , ... February 17, 2017 ... ... of software tools that allow for the electronic prescribing of controlled and non-controlled ... , Ninety percent of pharmacies in the United States now accept electronic ...
(Date:2/17/2017)... ... 17, 2017 , ... Qualis Health, one of the nation's ... Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs that ... multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... ... 2017 , ... PrideStaff, a national staffing organization, is pleased ... Industry Analysts' 2017 "Staffing 100 North America" list. , Now in its ... the staffing industry over the last twelve months. Industry insiders and observers nominate ...
(Date:2/17/2017)... ... 2017 , ... Dillon Ruxton Insurance, a Florida-based agency offering ... the greater Fort Lauderdale metropolitan region, is embarking on a cooperative food drive ... LifeNet 4 Families has provided a broad range of food provision services to ...
Breaking Medicine News(10 mins):